Published: 29 January, 2025 | Volume 9 - Issue 1 | Pages: 001-006
Figure 4:
Recombinant nanobody samples obtained from the different purification processes and from the AFF elution were compared in terms of inhibition rate against SFTS HB29 virus showing similar results.
Read Full Article HTML DOI: 10.29328/journal.aac.1001053 Cite this Article Read Full Article PDF
HSPI: We're glad you're here. Please click "create a new Query" if you are a new visitor to our website and need further information from us.
If you are already a member of our network and need to keep track of any developments regarding a question you have already submitted, click "take me to my Query."